Graphite Bio Raises $150M to Advance GPH101, Other Gene-editing Therapies

April 19, 2021

According to Aisha Abdulah, PHD, Graphite Bio has raised $150 million for gene editing therapy that could lead to a cure for Sickle Cell Disease. The follow article can be found here: https://sicklecellanemianews.com/2021/03/25/graphite-bio-raises-150m-dollars-to-advance-gene-editing-therapies-including-gph101-for-scd/